Article thumbnail

Critical Role of the Virus-Encoded MicroRNA-155 Ortholog in the Induction of Marek's Disease Lymphomas

By Yuguang Zhao, Hongtao Xu, Yongxiu Yao, Lorraine P. Smith, Lydia Kgosana, James Green, Lawrence Petherbridge, Susan J. Baigent and Venugopal Nair

Abstract

Notwithstanding the well-characterised roles of a number of oncogenes in neoplastic transformation, microRNAs (miRNAs) are increasingly implicated in several human cancers. Discovery of miRNAs in several oncogenic herpesviruses such as KSHV has further highlighted the potential of virus-encoded miRNAs to contribute to their oncogenic capabilities. Nevertheless, despite the identification of several possible cancer-related genes as their targets, the direct in vivo role of virus-encoded miRNAs in neoplastic diseases such as those induced by KSHV is difficult to demonstrate in the absence of suitable models. However, excellent natural disease models of rapid-onset Marek's disease (MD) lymphomas in chickens allow examination of the oncogenic potential of virus-encoded miRNAs. Using viruses modified by reverse genetics of the infectious BAC clone of the oncogenic RB-1B strain of MDV, we show that the deletion of the six-miRNA cluster 1 from the viral genome abolished the oncogenicity of the virus. This loss of oncogenicity appeared to be primarily due to the single miRNA within the cluster, miR-M4, the ortholog of cellular miR-155, since its deletion or a 2-nucleotide mutation within its seed region was sufficient to inhibit the induction of lymphomas. The definitive role of this miR-155 ortholog in oncogenicity was further confirmed by the rescue of oncogenic phenotype by revertant viruses that expressed either the miR-M4 or the cellular homolog gga-miR-155. This is the first demonstration of the direct in vivo role of a virus-encoded miRNA in inducing tumors in a natural infection model. Furthermore, the use of viruses deleted in miRNAs as effective vaccines against virulent MDV challenge, enables the prospects of generating genetically defined attenuated vaccines

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3044692
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2009). A functional MicroRNA-155 ortholog encoded by the oncogenic Marek’s disease virus.
  2. (2007). A viral microRNA functions as an orthologue of cellular miR-155.
  3. (2009). Causes and consequences of microRNA dysregulation in cancer.
  4. (2009). Differential expression of microRNAs in Marek’s disease virus-transformed T-lymphoma cell lines.
  5. (2009). Homodimerization of Marek’s disease virus-encoded Meq protein is not sufficient for transformation of lymphocytes in chickens.
  6. (2009). Homodimerization of the Meq viral oncoprotein is necessary for induction of T-cell lymphoma by Marek’s disease virus.
  7. (2009). Interaction of Marek’s disease virus oncoprotein Meq with heat-shock protein 70 in lymphoid tumour cells.
  8. (2006). Interaction of MEQ protein and C-terminal-binding protein is critical for induction of lymphomas by Marek’s disease virus.
  9. (2008). Kaposi’s sarcoma herpes virus taps into a host microRNA regulatory network.
  10. (2010). Marek’s disease virus microRNA designated Mdv1-pre-miR-M4 targets both cellular and viral genes.
  11. (2004). Marek’s disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable for replication.
  12. (1986). Marek’s disease: a model for herpesvirus oncology.
  13. (2008). Marek’s Disease. In:
  14. (2008). MicroRNA profile of Marek’s disease virus-transformed T-cell line MSB-1: predominance of virusencoded microRNAs.
  15. (2009). MicroRNAs and cancer: short RNAs go a long way.
  16. (2009). miR-155: on the crosstalk between inflammation and cancer.
  17. (2008). Oncogenes and cancer.
  18. (2010). Pivotal advance: Kaposi’s sarcoma-associated herpesvirus (KSHV)-encoded microRNA specifically induce IL-6 and IL-10 secretion by macrophages and monocytes.
  19. (2010). Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA.
  20. (2008). Sequence conservation and differential expression of Marek’s disease virus microRNAs.
  21. (2008). The history of tumor virology.
  22. (2009). Viral and cellular messenger RNA targets of viral microRNAs.